This inventor holds 9 USPTO granted patents, plus 2 CIPO patents and 3 EPO patents. Top assignees: Amgen Inc., Scripps Research Institute. Active years: 2005-2013.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2005-2013
Title: Guo-Qiang Cao: Innovator in Prolyl Hydroxylase Inhibition
Introduction
Guo-Qiang Cao is a prominent inventor based in Thousand Oaks, CA (US). He has made significant contributions to the field of biochemistry, particularly in the development of compounds that inhibit prolyl hydroxylases. With a total of 9 patents to his name, his work has implications for various therapeutic applications.
Latest Patents
Cao's latest patents include innovative compounds such as Azaquinolones that inhibit prolyl hydroxylase. These compounds, defined by specific structural formulas, are useful inhibitors of HIF prolyl hydroxylases. Another notable patent involves Azaquinolone-based compounds exhibiting prolyl hydroxylase inhibitory activity, which are also valuable in inhibiting HIF prolyl hydroxylases.
Career Highlights
Throughout his career, Guo-Qiang Cao has worked with leading organizations in the biotechnology sector. He has been associated with Amgen Inc. and The Scripps Research Institute, where he has contributed to groundbreaking research and development.
Collaborations
Cao has collaborated with notable colleagues, including Anthony B Reed and Jennifer Rebecca Allen, enhancing the impact of his research through teamwork and shared expertise.
Conclusion
Guo-Qiang Cao's innovative work in the field of prolyl hydroxylase inhibition showcases his dedication to advancing biochemistry. His patents and collaborations reflect his significant contributions to science and medicine.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile